“PO12 | Characterisation and Real Word Clinical Data of HEM006, a Newly Formulated Intranasal Spray Desmopressin (DDAVP) to Address a Global Treatment Gap: G. De Giorgi1, A. Gringeri2, R. Franceschini1, A. Koganti3 | 1Hemorare Srl, Italy; 2Fondazione Charta, Milan, Italy; 3Quenya LLC, USA”. 2025. Bleeding, Thrombosis and Vascular Biology 4 (s1). https://doi.org/10.4081/btvb.2025.274.